Luye Pharma Group Ltd Cash Flow Quality Index
Luye Pharma Group Ltd cash flow quality index. Luye Pharma Group Ltd (LUP) has a Cash Flow Quality Index of 4.60x as of June 2023. Operating cash flow of €344.86 Million exceeds net income of €74.99 Million, indicating high earnings quality where cash backs reported profits. See Luye Pharma Group Ltd free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Luye Pharma Group Ltd (2016–2025)
Cash flow quality index of Luye Pharma Group Ltd from 2016 to 2025. Historical Cash Flow Quality Index for Luye Pharma Group Ltd across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore LUP cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Luye Pharma Group Ltd Cash Flow Quality Index by Year (2016–2025)
Luye Pharma Group Ltd cash flow quality index by year from 2016 to 2025. Year-by-year earnings quality comparison for Luye Pharma Group Ltd. For the full cash flow conversion analysis, see Luye Pharma Group Ltd (LUP) cash flow conversion.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.88x | €1.78 Billion | €618.75 Million | ▲ +710.6% |
| 2024 | 0.36x | €167.76 Million | €471.89 Million | ▼ -88.1% |
| 2023 | 3.00x | €1.60 Billion | €532.61 Million | ▲ +9.6% |
| 2022 | 2.73x | €1.65 Billion | €604.81 Million | ▲ +87.0% |
| 2020 | 1.46x | €1.03 Billion | €706.59 Million | ▲ +51.0% |
| 2019 | 0.97x | €1.42 Billion | €1.47 Billion | ▲ +20.8% |
| 2018 | 0.80x | €1.05 Billion | €1.30 Billion | ▼ -18.3% |
| 2017 | 0.98x | €964.10 Million | €981.37 Million | ▲ +47.9% |
| 2016 | 0.66x | €592.03 Million | €891.54 Million | — |